Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FKBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RIPPLY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARNTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR637 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIPK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MITD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTLC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on